Literature DB >> 57508

Circulating hormone concentrations in women with breast cancer.

I J McFadyen, A P Forrest, R J Prescott, M P Golder, G V Groom, D R Fahmy, K Griffiths.   

Abstract

Multiple plasma-hormone concentrations were measured in sequential plasma-samples from six women with breast cancer and were compared to concentrations in six control women matched for age, years since menopause, and parity. All hormone concentrations in all the women studied were within normal limits. However, within the normal range the plasma-testosterone concentrations in each cancer patient were significantly higher than in each matched control.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 57508     DOI： 10.1016/s0140-6736(76)90064-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  12 in total

Review 1.  Factors influencing estrogen production and metabolism in postmenopausal women with endocrine cancer.

Authors:  V H James; E J Folkerd; R C Bonney; P A Beranek; M J Reed
Journal:  J Endocrinol Invest       Date:  1982 Sep-Oct       Impact factor: 4.256

2.  Corpus luteum dysfunction and the epidemiology of breast cancer: a reconsideration.

Authors:  B M Sherman; R B Wallace; S G Korenman
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

3.  Diminished corticosterone levels in nude mice implanted with MCF-7 or ZR-75-1 human breast tumor cells.

Authors:  S Lehrer; E Diamond; H K Song; W D Bloomer; R Blumenthal
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

Review 4.  Nutrition, hormones, and breast cancer: is insulin the missing link?

Authors:  R Kaaks
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

5.  Serum hormone levels in British and rural Chinese females.

Authors:  D Y Wang; T J Key; M C Pike; J Boreham; J Chen
Journal:  Breast Cancer Res Treat       Date:  1991-05       Impact factor: 4.872

6.  A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.

Authors:  G Ursin; S London; F Z Stanczyk; E Gentzschein; A Paganini-Hill; R K Ross; M C Pike
Journal:  Environ Health Perspect       Date:  1997-04       Impact factor: 9.031

Review 7.  Endogenous estrogens and breast cancer risk: the case for prospective cohort studies.

Authors:  P G Toniolo
Journal:  Environ Health Perspect       Date:  1997-04       Impact factor: 9.031

8.  A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey.

Authors:  H V Thomas; T J Key; D S Allen; J W Moore; M Dowsett; I S Fentiman; D Y Wang
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Hormone levels in older women: a study of post-menopausal breast cancer patients and healthy population controls.

Authors:  L Bernstein; R K Ross; M C Pike; J B Brown; B E Henderson
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

Review 10.  Estrogen replacement therapy (ERT) in high-risk cancer patients.

Authors:  K A Hutchinson-Williams; J N Gutmann
Journal:  Yale J Biol Med       Date:  1991 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.